Medical Management of Type 2 Diabetes
en Limba Engleză Paperback – 19 aug 2020
Medical Management of Type 2 Diabetes provides health care providers with all of the answers to their questions about implementing scientifically proven clinical care for their patients with type 2 diabetes.
As type 2 diabetes continues its disturbing rise in prevalence worldwide, there is an increasing need to study the disease and describe successful treatment regimens. There are several options for treatment, including oral medications, diet and lifestyle modification, and insulin therapy. Knowing which treatment method to select for a patient and how to apply it relies on several clinical guidelines that are updated every year by the American Diabetes Association.
This new edition features:
- Details on the newest agents for the treatment of type 2 diabetes
- Expanded information on pharmacological intervention
- Updated data on chronic and acute complications
- The latest standards of medical care from the American Diabetes Association
This essential resource will enhance the clinical knowledge of type 2 diabetes and bolster the skills necessary to care for patients with diabetes.
Preț: 226.68 lei
Preț vechi: 311.84 lei
-27% Nou
43.38€ • 45.49$ • 36.17£
Carte indisponibilă temporar
Specificații
ISBN-10: 1580406319
Pagini: 184
Dimensiuni: 152 x 229 x 18 mm
Greutate: 0.48 kg
Ediția:Eighth Edition
Editura: American Diabetes Association
Notă biografică
Luigi Meneghini, MD, MBA, is a Professor of Internal Medicine at the University of Texas Southwestern Medical Center, Division of Endocrinology, in Dallas, Texas, and Executive Director of the Parkland Health and Hospital System Global Diabetes Program. Prior to joining UT Southwestern, he was he was Professor of Clinical Medicine at the University of Miami Miller School of Medicine and Director of the Kosow Diabetes Treatment Center.
Dr. Meneghini is a frequent lecturer and has published numerous articles in peer-reviewed medical journals. He has presented numerous projects at the Scientific Sessions of the American Diabetes Association and the European Association for the Study of Diabetes. Dr. Meneghini¿s primary interests lie in improving the lives of patients with diabetes through the application of cutting edge therapies and technologies, and the implementation of these treatment strategies through patient and professional education activities.